Latest Financial Position News

Kelsian Group signals a cautious FY25 outlook with EBITDA tracking at the lower end of guidance, while advancing strategic tourism divestments and securing key contract renewals.

MyEco Group has secured $1.6 million through unsecured convertible notes to support a strategic operational restructure aimed at reducing costs and scaling production. This capital raise complements existing cash reserves and aims to improve margins while minimising shareholder dilution.

Brightstar Resources outlines an ambitious growth plan targeting over 200,000 ounces of gold production annually by 2029, driven by expansions at Laverton and Menzies hubs and accelerated development of the Sandstone project.

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

Wellnex Life Limited announces key board and management changes following its successful AIM Market dual listing, including the resignation of its Non-Executive Chairman and appointment of a joint CEO to drive growth.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.

Chalice Mining reports significant metallurgical improvements at its Gonneville Project, boosting metal recoveries and revealing a promising iron byproduct that could enhance project economics.

Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.

Healius Limited has announced a special fully franked dividend of AUD 0.413 per ordinary share, signaling confidence in its financial position despite the ongoing suspension of its Dividend Reinvestment Plan.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

Saturn Metals has significantly upsized its Share Purchase Plan to $9.25 million, raising total capital of $32.25 million to accelerate development of its Apollo Hill Gold Project and expand exploration in Western Australia.

Chrysos Corporation reported a 25% year-on-year revenue increase in Q3 FY25, driven by strong growth in sample volumes and expanded deployment of its PhotonAssay technology across key mining regions.